LXX Chart by TradingView

Business Description

Lexaria Bioscience Corp. (“Lexaria”, “Company”) is a life sciences company that has recently received patent protection for their DehydraTECH™ technology from the U.S. Patent and Trademark Office.

Website: https://www.lexariabioscience.com/


FRC Analyst's Reports

Lexaria Bioscience (CSE: LXX) Focus Seemingly on R&D as Licensing Revenues Slow May. 7, 2019
Lexaria Bioscience (CSE: LXX) Landmark Partnership with Tobacco Titan Feb. 5, 2019
Lexaria (CSE: LXX) Additional Licensees and Expanded IP Aug. 31, 2018
Lexaria (OTCQX: LXRP / CSE: LXX) Initial Cannabis Focus; Multi-Market Potential Jan. 12, 2018


News

Lexaria Appoints New Chief Financial Officer and Issues Consultant Warrants Apr. 15, 2021
Lexaria Bioscience: Turning the Tide on Hypertension Apr. 15, 2021
Lexaria’s DehydraTECHTM Technology Utilized in Amari’s “Everyday Calm,” Named a Top CBD Product Pick by New Hope Network Apr. 14, 2021
Lexaria Is Expanding CBD Use Beyond Medical Applications into $2.65 Billion Marketplace Apr. 8, 2021
Lexaria to Evaluate DehydraTECH(TM) in Multiple New Markets Apr. 6, 2021